{"id":"c5677c1a-8c95-438d-9619-849950504010","name":"NeuroLutions","slug":"neurolutions","description":"NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.","status":null,"founded":2007,"hq":"St. Louis, Missouri, USA","hqLat":null,"hqLng":null,"hqGeocodedAt":null,"hqAddress":null,"hqPrecision":null,"website":"neurolutions.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/","title":"Stroke-recovery device using brain-computer interface receives FDA market authorization","sourceName":"Washington University School of Medicine"}],"keyFacts":[{"label":"FDA","value":"First FDA-cleared BCI for stroke rehab"},{"label":"Product","value":"IpsiHand"},{"label":"Type","value":"Non-invasive BCI"},{"label":"Parent","value":"Kandu Inc."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:36.733Z","updatedAt":"2026-08-08T22:39:09.284Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/neurolutions","url":"https://registry.deploy.report/companies/neurolutions","name":"NeuroLutions","description":"NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.","identifier":"c5677c1a-8c95-438d-9619-849950504010","foundingDate":"2007","address":"St. Louis, Missouri, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}